Suchergebnisse - "van de Donk, Niels W C J"

PubPharm (215)

61

Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1) : a multicentre, open-label, single-arm, phase 1 study

enthalten in: Lancet (London, England) | 2021

von Usmani, S. | Garfall, A. | van de Donk, N. | +18

CommentIn: Nat Rev Clin Oncol. 2021 Oct;18(10):604. - PMID 34453130

62

Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference

enthalten in: Clinical chemistry and laboratory medicine | 2021

von Noori, S. | Verkleij, C. | Zajec, M. | +8

63

Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference

enthalten in: Clinical chemistry and laboratory medicine | 2021

von Noori, S. | Verkleij, C. | Zajec, M. | +8

64

Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib/thalidomide/dexamethasone in the phase 3 CASSIOPEIA study

enthalten in: Haematologica | 2021

von Hulin, C. | Offner, F. | Moreau, P. | +20

65

Expert review on soft-tissue plasmacytomas in multiple myeloma : definition, disease assessment and treatment considerations

enthalten in: British journal of haematology | 2021

von Rosiñol, L. | Beksac, M. | Zamagni, E. | +35

66

European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma

enthalten in: Haematologica | 2021

von Bruno, B. | Wäsch, R. | Engelhardt, M. | +14

67

Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma

enthalten in: Blood cancer discovery | 2021

von van de Donk, N. | Themeli, M. | Usmani, S.

68

CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells : A Proof of Concept for an "Off the Shelf" Therapy for Multiple Myeloma

enthalten in: HemaSphere | 2021

von Stikvoort, A. | van der Schans, J. | Sarkar, S. | +11

69

Comparison of CD38 antibodies in vitro and ex vivo mechanisms of action in multiple myeloma

enthalten in: Haematologica | 2021

von Kinder, M. | Bahlis, N. | Malavasi, F. | +7

70

Bone Marrow Mesenchymal Stromal Cells Can Render Multiple Myeloma Cells Resistant to Cytotoxic Machinery of CAR T Cells through Inhibition of Apoptosis

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Holthof, L. | van der Schans, J. | Katsarou, A. | +10